Trial
NCT01722292
A Study of LY2940680 in Small Cell Lung Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Small Cell Lung Carcinoma
Intervention
LY2940680
Why stopped
Change in clinical strategy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-28